Press release Oncology Venture to present on its DRP® technology at upcoming Google Cloud NEXT Conference.

NEXT STORY
$5+ Billion Antimicrobial Susceptibility Testing Market by Product, Method, Application and End User – Global Forecast to 2027
PREV STORY
Kiadis Pharma announces FDA clearance of clinical study by The Ohio State University in R/R AML with off-the-shelf NK cells from universal donors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Health Canada has approved TALTZ® (ixekizumab) for the Treatment of Active Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis)

author_avatar
NASDAQ Market News

Biocartis Group NV: BIOCARTIS KONDIGT 2018 RESULTATEN EN 2019 VOORUITZICHTEN AAN

author_avatar
NASDAQ Market News

Novartis a enregistré, au troisième trimestre, une forte croissance et fait preuve d’une innovation dynamique, incluant des plateformes thérapeutiques avancées pour soutenir la croissance future

Hausse du chiffre d'affaires net de 6% (tcc[1], +3% USD), stimulée principalement par: Cosentyx, qui ...

author_avatar
NASDAQ Market News